Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
(d)
|
Exhibits.
|
Exhibit
Number
|
Description
|
99.1
|
Press
release dated May 5, 2009.
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By:
|
/s/ Chang H.
Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive Officer
|
Date:
|
May
5, 2009
|
Exhibit
Number
|
Description
|
Press
release dated May 5, 2009.
|